Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Cyanide, Bombardier and healthcare AI

Investors seem to be keeping their money at home this summer, given how the markets have performed in Toronto and New York. In New York, the Nasdaq and the S&P 500 reached new trading highs on more than one occasion in the past few days alone. This was driven by stron...

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...

Silver price predictions: Is the 2024 gold and silver rally just starting?

By Rob Driscoll Like birds of a feather, gold and silver have historically flocked together, and the two precious metal mates have certainly found their wings in 2024. Gold hit an all-time high in April, and silver parroted the move by breaching the $29 mark l...

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Last week saw the Canadian and U.S. stock markets grappling with a host of challenges, from surging inflation data to escalating tensions in the Middle East. Adding to the mix, a historic trial commenced in New York, as former U.S. President Donald Trump faced allegations...

Emerging opportunity in a growing, high-value dermatological market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Kane Biotech Inc. (TSXV:KNE) , a Canadian-based biotech company engaged in the development and commercialization of products that prevent and remove microbial biof...

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...

17 best payday loans online: Quick cash and fast approval this Christmas

If you face a financial emergency, traditional loans may not be a viable option if you have bad credit. So what can you do when you need quick cash – especially close if you need cash for Christmas gifts during the festive season? The best online payday loans are an a...

Data speeds are increasing to 1.6T – what does that mean for you?

By POET Technologies The internet is getting faster and what’s making it happen is the increase in data speeds from 400G to 800G and 1.6T – and eventually beyond. Modern life demands these increases because our world has an insatiable desire for ban...

Proving up high-grade gold at district scale

The gold-hosting trend on Westhaven Gold’s flagship Shovelnose project in British Columbia covers just a small fraction of the district-scale property. Now, Westhaven has hit high-grade gold well off that trend … and it’s pointing...
1 2 3 4 5 6 7 8 9 10 ...